""
UC Davis Medicine Logo
The institution's principal publication for alumni, friends and physicians.
""
Horizontal boundary
""
""
"" "" ""
  N E W S  
"" "" ""
"" New fragile X syndrome test ""
""

""

""
"" Regaining impulse control ""
""

""

""
"" Early attention problems affect high school graduation ""
""

""

""
  National autism study partner  
""

""

""
  Working Professional MBA Program relocates to Sacramento campus  
""

""

""
  Depression, cognitive decline linked in older Latino couples  
""

""

""
  Forming new blood vessels  
""

""

""
  New stem cell grants  
""

""

""
  New synapse formation imaged  
""

""

""
  Job-related hypertension lingers  
""

""

""
  Level I status for trauma center  
""

""

""
  Foundation research award  
""

""

""
  Nesbitt leads technology advancement, partnership development  
""

""

""
  Albertson acting chair for Internal Medicine  
""

""

""
  Meyers new executive associate dean  
""

""

""
 

New Radiation Oncology chair

 
""

""

""
 

Hales M.I.N.D. Institute's acting director

 
""

""

""
 

New trauma program chief

 
Vertical Seperator Line
""
""
NEWS
""
""
"" ""
"" ""
 
""

Foundation research award

 "" PHOTO — Schizophrenia researcher Michael Minzenberg will track the effectiveness of a drug in treating schizophrenia using functional magnetic resonance imaging (fMRI) of the prefrontal cortex, which controls executive abilities such as planning, using rules, inhibiting inappropriate actions and prioritizing sensory input.
 
Schizophrenia researcher Michael Minzenberg will track the effectiveness of a drug in treating schizophrenia using functional magnetic resonance imaging (fMRI) of the prefrontal cortex, which controls executive abilities such as planning, using rules, inhibiting inappropriate actions and prioritizing sensory input.
"" ""

The Doris Duke Charitable Foundation has selected Michael Minzenberg for a 2009 Clinical Scientist Development Award for his pioneering work in treating schizophrenia. An assistant professor of psychiatry and behavioral sciences, Minzenberg studies the neurochemical systems that regulate cognitive, emotional and social processes and how this circuitry goes awry in personality disorders and schizophrenia. He is one of only 14 physician-scientists nationwide selected in 2009 to receive foundation support of $135,000 per year for three years for biomedical discoveries and their translation into new treatments, preventions and cures for human diseases. The funding will help Minzenberg find out if a novel medication can restore impaired cognitive processes by tracking it with functional magnetic resonance imaging (fMRI) of the prefrontal cortex. The foundation's funding is intended to help researchers establish project teams and protect a portion of their professional time for clinical research.

""
"" ""
 
"" ""
"" ""
Vertical Seperator Line
"" "" ""
     
"" "" Vertical Seperator Line "" "" "" ""
"" "" Vertical Seperator Line
""
""

UC DAVIS SCHOOL OF MEDICINE
PUBLIC AFFAIRS
4900 Broadway, Suite #1200
Sacramento, CA 95820

© 2009 UC Regents. All rights reserved.

"" "" ""